Journal Referees Report That Authors Call Many Of The Shots

Publish or perish. It's a dictum drummed into the heads of scientists from the time they begin their studies. Jobs, grants, and promotions--everything of possible import to the budding academic scientist--hinge, to a great extent, on getting one's research into print. But self-advancement also goes hand-in-hand with the progress of science, for publishing papers is the prime means by which important findings are disseminated within the scientific community. To publish a paper in a journal, wher

Written byJeff Seiken
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

In light of the pressure to publish felt by most investigators, it's only natural for them to view with some trepidation the system by which journals evaluate papers. Cloaked in confidentiality as it generally is, the process of refereeing can seem altogether mystifying, like some sort of cabalistic rite. But in reality, there's nothing particularly mysterious--or sinister--about what happens to a manuscript once the hopeful author deposits it in the mail.

Editors and reviewers say they approach their jobs not as authors' adversaries, but as colleagues. Stanley Brown, an editor at the journal Physical Review, speaks for many when he says, "We bend over backwards for authors."

Statistics bear this out. While an interdisciplinary publication like Science may reject about 80 percent of the manuscripts it receives, most journals are considerably less picky. In fact, a 1971 study by Columbia University sociologists Harriet Zuckerman and Robert Merton found that major ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies